Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- City of Hope
- University of British Columbia
- Michigan State University
- Dana-Farber Cancer Institute (DFCI)
- New England HERC
- National University of Singapore
- University of Maryland, Baltimore
- Indiana University
- University of Birmingham
- Baylor College of Medicine
- King's College London
- Saint Louis University
- University of Colorado
- University of Copenhagen
- Aarhus University
- Albert Einstein College of Medicine (Bronx, NY)
- Boehringer Ingelheim International GmbH
- Center for Drug Evaluation and Research (CDER)
- Cleveland Clinic
- Ellison Institute of Technology
- Francis Crick Institute
- Johns Hopkins Medicine - Laboratory of Human Biomimetics
- La Jolla Institute for Immunology - Human Resources
- Luxembourg Institute of Health (LIH)
- MD Anderson Cancer Center - Department of Lymphoma/Myeloma
- MRC Laboratory of Medical Sciences
- Mayo Clinic
- Mayo Clinic, Rochester
- Microbiomes Institute — University of South Florida
- Nanyang Technological University
- National Institutes of Health (NIH)
- Northeastern University
- Pennsylvania State University
- St Jude Children's Research Hospital
- THE UNIVERSITY OF HONG KONG
- The Francis Crick Institute
- The University of Queensland
- The University of Texas MD Anderson Cancer Center
- UCL
- UNIVERSITY OF WISCONSIN-MADISON Biomolecular Chemistry
- Umeå University
- Univ. Alabama, Birmingham
- University of Aberdeen
- University of Basel
- University of British Columbia - Department of Medicine
- University of Lund
- University of North Carolina at Charlotte
- 37 more »
- « less
-
Field
-
Focus Our program leverages multi-omics platforms (including proteomics, metabolomics, transcriptomics), targeted biomarker arrays, and advanced computational approaches to: Characterize biomarker
-
profiling data sets from PTLD patient and control patient blood and are performing single cell spatial transcriptomics to analyse the immune microenvironment of PTLD tumours. The appointed candidate will
-
datasets (e.g., proteomics, transcriptomics, imaging, clinical, and biomarker data). The position is ideal for a candidate interested in mechanistic discovery, biomarker development, and translational
-
UNIVERSITY OF WISCONSIN-MADISON Biomolecular Chemistry | Madison, Wisconsin | United States | about 1 month ago
, mouse models, cell-based systems, molecular and immunological approaches, flow cytometry, single-cell analysis, multi-omics, spatial transcriptomics, and bioinformatics . Representative publications
-
apply and develop computational methods to analyze datasets of varying modalities, such as RNA -seq, ATAC -seq, and spatial transcriptomics datasets, and of paired molecular and functional measurements
-
and multi-omics technologies. Depending on the project, approaches may include microbial genome sequencing, metagenomics, metabolomics, transcriptomics, single-cell or spatial profiling, and
-
transcriptomics) provide rich information about cellular heterogeneity, but typically capture biological systems only at discrete snapshots in time. We are seeking a PDF to join our collaborative research team
-
fungicide resistance, host–pathogen interactions, and disease resistance in turfgrass systems. The role will integrate omics approaches (e.g., genomics, transcriptomics) and bioinformatics to better
-
: · Perform collaborative research with multiple faculty members at ARDMRI on projects involving genomics data analysis using single cell RNA-seq, CHIP-seq/ATAC-seq, spatial transcriptomics
-
mouse models of lung injury and fibrosis, human lung samples, alveolar epithelial organoids, flow cytometry, molecular and cellular biology, single-cell RNA-seq, spatial transcriptomics, and multi